Join to View Full Profile
3181 Sw Sam Jackson Park RdCdrc-PPortland, OR 97239
Phone+1 503-494-5856
Fax+1 503-494-2370
Dr. Finanger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Neuromuscular Medicine (Neurology), 2008 - 2009- Johns Hopkins UniversityFellowship, Child Neurology, 2005 - 2008
Mayo Clinic College of MedicineClass of 2003
Certifications & Licensure
OR State Medical License 2009 - 2025
WA State Medical License 2023 - 2025
MD State Medical License 2008 - 2010
MN State Medical License 2004 - 2005
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
Clinical Trials
- A Study of Tadalafil for Duchenne Muscular Dystrophy Start of enrollment: 2013 Sep 01
- A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy Start of enrollment: 2014 Aug 19
- Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy Start of enrollment: 2015 Jun 30
Publications & Presentations
PubMed
- Characterization of severe COL6-related dystrophy due to the recurrent variant COL6A1 c.930+189C>T.A Reghan Foley, Véronique Bolduc, Fady Guirguis, Sandra Donkervoort, Ying Hu
Brain. 2025-04-03 - 1 citationsThe recurrent deep intronic pseudoexon-inducing variantc.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readin...A Reghan Foley, Véronique Bolduc, Fady Guirguis, Sandra Donkervoort, Ying Hu
Medrxiv. 2024-03-29 - 2 citationsBiallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.Lauren Jeffries, Emily K Mis, Kirsty McWalter, Sandra Donkervoort, Nina N Brodsky
Genetics in Medicine. 2024-02-01
Press Mentions
Local Girl Receives First at-Home Treatment for Rare DiseaseNovember 13th, 2020
Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business ProgressMay 12th, 2020
Edasalonexent May Limit Disease Progression in Boys with Duchenne MD, Phase 1/2 Trial ShowsMarch 1st, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
